In the News

Watch Dr. Ferrara’s Journal of Clinical Investigation Interview discussing GVHD


Read about the First, Predictive Acute Graft Versus Host Disease (aGVHD) Algorithms with Clinical Cutoffs to Predict Risk of Graft vs. Host Disease & Non-Relapse Mortality for HCT Patients


Read about a new $10 million grant given to the Tisch Cancer Institute to study GVHD


Read a report of how biomarkers can be used to predict GVHD prior to any symptoms developing


Watch Dr. Ferrara discuss GVHD


Watch Dr. Ferrara present the latest research on GVHD at the Mount Sinai medical grand round


Watch Dr. Ferrara’s discussion at Arise America – Fighting Blood Cancers


Read about Biomarkers predicted severity of GVHD after allogeneic HSCT Hematology Oncology


Read Inside Mount Sinai – A New Era for Bone Marrow Transplantation